potassium phosphate inj 3mmp/ml solution
hospira healthcare ulc - potassium phosphate monobasic; potassium phosphate dibasic - solution - 224mg; 236mg - potassium phosphate monobasic 224mg; potassium phosphate dibasic 236mg - replacement preparations
potassium phosphate monobasic injection solution
sandoz canada incorporated - potassium phosphate monobasic - solution - 176mg - potassium phosphate monobasic 176mg - replacement preparations
potassium phosphates injection, solution potassium phosphates- potassium phosphate, monobasic potassium phosphate, dibasic inje
american regent, inc. - potassium phosphate, monobasic (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr), potassium phosphate, dibasic (unii: ci71s98n1z) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr) - potassium phosphates injection is indicated as a source of phosphorus: - in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. - for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. potassium phosphates injection is contraindicated in patients with: - hyperkalemia [see warning and precautions (5.3)] - hyperphosphatemia [see warning and precautions (5.4)] - hypercalcemia or significant hypocalcemia [see warning and precautions (5.4)] - severe renal impairment (egfr less than 30 ml/min/1.73m2 ) or end stage renal disease [see warning and precautions (5.3)] risk summary administration of the recommended dose of potassium phosphates injection is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with potassium phosphates inj
potassium phosphate concentrate (rem)
paragon care group new zealand limited - dibasic potassium phosphate 2 meq/ml; monobasic potassium phosphate 2 meq/ml - solution for infusion - 2 meq/ml - active: dibasic potassium phosphate 2 meq/ml monobasic potassium phosphate 2 meq/ml
potassium phosphate monobasic
jurox pty limited - potassium phosphate monobasic - unknown - potassium phosphate monobasic mineral-potassium active 0.0 - active constituent
monobasic potassium phosphate
abbey laboratories pty ltd - potassium phosphate monobasic - unknown - potassium phosphate monobasic mineral-potassium active 0.0 - active constituent
artisial liquid
jouveinal inc. - potassium phosphate dibasic; potassium phosphate monobasic; calcium chloride; potassium chloride; sodium chloride; magnesium chloride - liquid - 80.3mg; 32.6mg; 16.625mg; 62.45mg; 86.55mg; 5.875mg - potassium phosphate dibasic 80.3mg; potassium phosphate monobasic 32.6mg; calcium chloride 16.625mg; potassium chloride 62.45mg; sodium chloride 86.55mg; magnesium chloride 5.875mg - eent drugs, miscellaneous
phosphate phebra
phebra pty ltd - monobasic sodium phosphate, quantity: 1.936 g - tablet, effervescent - excipient ingredients: potassium bicarbonate; citric acid; sucrose; macrogol 4000; saccharin sodium; sodium bicarbonate; flavour - 1) hypercalcaemia associated with such conditions as hyperparathyroidism, multiple myelomatosis, and metastatic bone disease.,2) hypophosphataemia associated with vitamin d resistant rickets.
dbl potassium dihydrogen phosphate concentrated injection 1.361g/10ml
pfizer australia pty ltd - monobasic potassium phosphate, quantity: 136.1 mg/ml - injection, concentrated - excipient ingredients: water for injections - treatment of severe hypophosphataemia (serum levels less than 0.3 mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. the cause of hypophosphataemia should be identified and treated.
vytrate liquid concentrate
zoetis australia pty ltd - glycine; citric acid monohydrate; glucose; potassium citrate; potassium phosphate monobasic; sodium chloride - oral solution/suspension - glycine amino acid-glycine active 38.56 g/l; citric acid monohydrate acid-general active 3.28 g/l; glucose carbohydrate active 278.75 g/l; potassium citrate mineral-potassium active 0.75 g/l; potassium phosphate monobasic mineral-potassium active 25.53 g/l; sodium chloride mineral-sodium-salt active 53.44 g/l - nutrition & metabolism - calf | cat | dog | horse foal | lamb | pigs | sheep ewe (female) | beef calf | bitch | boar | bovine | calf - poddy | calf - pre - bought in - first feed | debilitating viral disease | dehydration | diarrhoea | electrolyte replacement | pregnancy toxaemia | rehydration | scours | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | selenium responsive scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours